Short Interest in Coeptis Therapeutics Holdings, Inc. (NASDAQ:ZSQR) Expands By 120.7%Market Beat·2 days ago, 07:00 AMCOEP0.00%ZSQR-1.32%
Z Squared Provides Details on Pro Rata Distribution and Nasdaq Trading StartTradingView·Apr 28 at 07:53 AMZSQR-1.32%COEP0.00%
Seaport and Hemab target $180m IPOs as biotech listings accumulatePharmaceutical Technology·Apr 28 at 05:22 AM426CVR015TMPCOEP0.00%
Z Squared Provides Additional Information on Previously Disclosed Pro Rata Distribution | ZSQR Stock NewsStockTitan·Apr 27 at 02:31 AMCOEP0.00%ZSQR-1.32%
Z Squared Announces Completion of Business Combination with Coeptis Therapeutics and Listing on the Nasdaq Global Market | COEP Stock NewsStockTitan·Apr 24 at 07:45 AMCOEP0.00%IXJ-1.16%
CoTec Receives $19.9 Million From Warrant Acceleration | CTHCF Stock NewsStockTitan·Apr 12 at 10:00 PMCOEP0.00%BBH-0.30%
CoTec Raises $17.4 Million as Warrant Acceleration Triggers High Exercise RateTip Ranks·Apr 8 at 07:03 PMPBE-3.00%XLV-1.64%
CoTec Provides Update on Warrant Acceleration | CTHCF Stock NewsStockTitan·Apr 8 at 10:55 AMIBBQ+0.90%PBE-3.00%
Coeptis Announces Approval of Z Squared Inc.’s Nasdaq Listing Application | COEP Stock NewsStockTitan·Apr 7 at 03:10 AMBIB+1.63%BBH-0.30%
Coeptis Therapeutics Holdings 2025 10-K: $1.36M Revenue, Operating Loss $14.23MTradingView·Mar 19 at 04:05 PMARKG+4.69%IBB+0.76%
